Haohai Biological Says Preliminary Figures Show Drop in 2025 Profit
MT Newswires Live
Yesterday
Shanghai Haohai Biological Technology (HKG:6826) said it expects a 40% year-on-year drop in its 2025 profit based on a preliminary estimate, according to a Hong Kong bourse filing Friday.
The firm posted 251 million yuan in attributable profit for the year, compared with 420.4 million yuan in 2024, according to the preliminary figures.
Basic earnings per share were 1.08 yuan, compared with 1.80 yuan in 2024.
Revenue fell 8% year-on-year to 2.47 billion yuan, the firm said, citing the preliminary data.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.